Red Book 2015: Report of the Committee on Infectious Diseases, Paperback, Thirtieth Edition by Kimberlin MD FAAP, David W.

Paperback: Thirtieth Edition
Brand New
9781581109269
1581109261

Publication Date: 2015-05-01
Paperback : 1152 pages
Edition: Thirtieth Edition
Author: Kimberlin MD FAAP, David W.
ISBN-10: 1581109261
ISBN-13: 9781581109269

Product Description 2015 Red Book is the American Academy of Pediatrics' authoritative guide to manifestations, etiology, epidemiology, diagnosis, and treatment of more than 200 childhood conditions. It provides evidence-based guidance to practicing clinicians on pediatric infections and vaccinations based on the recommendations of the committee as well as the combined expertise of the CDC, the FDA and hundreds of physician contributors. The Red Book is an essential reference for pediatric infectious diseases specialists and general pediatricians, and is useful for family medicine and emergency medicine physicians as well. Public health and school health providers, medical residents and students also will find it a high-yield source of pediatric infectious disease and vaccine information. The book is divided into sections that cover Active and passive immunization Disease summaries Antimicrobial therapy for treatment and prophylaxis Care of children in special situations Updated information and recommendations you cannot afford to be without... Standardized approach to disease prevention through immunizations, antimicrobial prophylaxis, and infection control practices New chapter on Hemorrhagic Fevers Caused by Filoviruses has been added New chapter on human parechovirus infections has been added Updated information on hypersensitivity reactions after immunizations The latest on sexually transmitted infections (STIs) in adolescents and children Updated coverage of actinomycosis, amebiases, arbovirus, bacterial vaginosis, blastocystis, candidiasis, Clostridium difficle, coronaviruses, dengue, enteroviruses, Escherichia coli, Giardia intestinalis, gonococcal infections, Helicobacter pylori infections, lyme disease, meningococcal infections, pediculosis capitis, pertussis, pneumococcal infections, rotavirus, and more Managing Injection Pain has been significantly expanded Updated information on hepatitis C Updated information on group B streptococcal infections Updated section on drugs for parasitic infections Significantly revised chapter on Respiratory Syncytial Virus Recommendations for using MMR or MMRV vaccines have been updated The Antimicrobial Resistance and Antimicrobial Stewardship chapter has been significantly broaded and updated Updated information on HIV And much more! Review 4-Star Review! "This is an unparalleled resource in both content and authority for pediatric infectious diseases knowledge, from diagnosis to management and prevention." Kari A. Simonsen, MD, University of Nebraska Medical Center Doody's Book Review About the Author David W. Kimberlin, MD, FAAP is the Principal Investigator for the Collaborative Antiviral Study Group (CASG), an international network of pediatric academic medical centers that evaluates antiviral therapeutics in rare diseases with a large unmet medical need, including neonatal herpes simplex virus (HSV) infections, congenital cytomegalovirus (CMV) disease, congenital Zika infection, neonatal and infantile influenza infection, and neonatal enteroviral sepsis syndrome. Studies conducted by the CASG have led to new drug indications and label changes for acyclovir, valganciclovir, and oseltamivir, and non-CASG studies conducted by Dr. Kimberlin also have led to label changes for valacyclovir.   Dr. Kimberlin is Editor of the 2018 AAP Report of the Committee on Infectious Diseases (Red Book). He also was Editor of the 2015 edition, and was an Associate Editor of the 2012 and 2009 editions. Dr. Kimberlin is a Past-President of the Pediatric Infectious Diseases Society (PIDS), which is the world's largest organization of professionals dedicated to the treatment, control, and eradication of infectious diseases affecting children. He also serves as Vice Chair for Clinical and Translational Research in the UAB Department of Pediatrics, where he holds the Sergio Stagno Endowed Chair in Pediatric Infectious Diseases and is Co-Director of the Division of Pediatric Infect